Abstract | OBJECTIVE: METHODS AND RESULTS: We performed a proteomic analysis in serum samples of 24 patients with ischemic stroke (12 atherothrombotic patients and 12 cardioembolic patients). In this study, based on two-dimensional electrophoresis and mass spectrometry we found four spots whose expression intensity was at least four times stronger in atherothrombotic patients than in cardioembolic patients. These spots were identified as haptoglobin related protein, serum amyloid A (two spots) and haptoglobin alpha chain. We validated the possible value of haptoglobin and serum amyloid A in a larger series of patients (n=262) with ischemic stroke using ELISA techniques. Haptoglobin levels >1040microg/mL identified atherothrombotic patients with 95% sensitivity and 88% specificity whereas serum amyloid A levels >160microg/mL identified atherothrombotic patients with 91% sensitivity and 83% specificity. CONCLUSIONS:
|
Authors | David Brea, Tomás Sobrino, Miguel Blanco, Máximo Fraga, Jesús Agulla, Manuel Rodríguez-Yáñez, Raquel Rodríguez-González, Natalia Pérez de la Ossa, Rogelio Leira, Jerónimo Forteza, Antonio Dávalos, José Castillo |
Journal | Atherosclerosis
(Atherosclerosis)
Vol. 205
Issue 2
Pg. 561-7
(Aug 2009)
ISSN: 1879-1484 [Electronic] Ireland |
PMID | 19171342
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers
- Haptoglobins
- Serum Amyloid A Protein
|
Topics |
- Aged
- Biomarkers
(blood, metabolism)
- Electrophoresis, Gel, Two-Dimensional
- Enzyme-Linked Immunosorbent Assay
- Female
- Haptoglobins
(biosynthesis)
- Humans
- Ischemia
(blood, diagnosis)
- Male
- Mass Spectrometry
(methods)
- Middle Aged
- Proteomics
(methods)
- Sensitivity and Specificity
- Serum Amyloid A Protein
(biosynthesis)
- Stroke
(blood, diagnosis)
- Thrombosis
(blood, diagnosis)
|